H.B. No. 1103 aims to enhance measures for preventing and responding to opioid-related drug overdoses at public institutions of higher education in Texas. The bill introduces a new subchapter, Subchapter Y-2, to Chapter 51 of the Education Code, which mandates that each institution adopt a policy ensuring the availability of opioid antagonists in residence halls. This includes provisions for the acquisition, maintenance, storage, administration, and disposal of these devices, as well as training for resident advisors on their proper use. The bill also requires that resident advisors be authorized to administer opioid antagonists to individuals suspected of experiencing an overdose.

Additionally, the bill outlines the responsibilities of institutions regarding training, reporting, and the prescription of opioid antagonists. It establishes immunity for individuals acting in good faith under the provisions of the subchapter, protecting them from civil or criminal liability related to the administration of opioid antagonists. Institutions are required to implement these measures by the fall semester of 2026, and the act will take effect immediately if it receives a two-thirds vote from both houses; otherwise, it will take effect on September 1, 2025.

Statutes affected:
Introduced: ()